Trial Outcomes & Findings for Hospital to Home Outcomes (NCT NCT02081846)
NCT ID: NCT02081846
Last Updated: 2019-04-16
Results Overview
The dependent variable will be a dichotomized indicator of any occurrence of unplanned rehospitalization and/or any emergency department/urgent care visit within 30-days post-discharge (i.e. unplanned reutilization). Differences in this outcome between intervention and control groups will be evaluated using logistic regression with the stratification variables (neighborhood poverty and complex versus noncomplex teams) included in the model.
COMPLETED
NA
1500 participants
30 days post-discharge
2019-04-16
Participant Flow
Patients hospitalized on the hospital medicine or neurosciences services (neurology/ neurosurgery) at Cincinnati Children's Hospital Medical Center (CCHMC), a freestanding tertiary care children's hospital, between 2/2015 and 4/2016 were eligible for study recruitment.
Participant milestones
| Measure |
Home Nurse Visit
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Overall Study
STARTED
|
751
|
749
|
|
Overall Study
COMPLETED
|
749
|
749
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
Reasons for withdrawal
| Measure |
Home Nurse Visit
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
0
|
|
Overall Study
invalid consent
|
1
|
0
|
Baseline Characteristics
Hospital to Home Outcomes
Baseline characteristics by cohort
| Measure |
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=749 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
Total
n=1498 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
2.1 years
n=5 Participants
|
1.9 years
n=7 Participants
|
2.0 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
357 Participants
n=5 Participants
|
364 Participants
n=7 Participants
|
721 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
392 Participants
n=5 Participants
|
385 Participants
n=7 Participants
|
777 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
34 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
65 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
704 Participants
n=5 Participants
|
709 Participants
n=7 Participants
|
1413 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
11 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · White
|
453 Participants
n=5 Participants
|
456 Participants
n=7 Participants
|
909 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Black or African American
|
219 Participants
n=5 Participants
|
210 Participants
n=7 Participants
|
429 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Asian/Oriental or Pacific Islander
|
3 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Other
|
64 Participants
n=5 Participants
|
62 Participants
n=7 Participants
|
126 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Unknown/missing
|
9 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
749 Participants
n=5 Participants
|
749 Participants
n=7 Participants
|
1498 Participants
n=5 Participants
|
|
Length of Stay
|
2 days
n=5 Participants
|
2 days
n=7 Participants
|
2 days
n=5 Participants
|
PRIMARY outcome
Timeframe: 30 days post-dischargePopulation: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).
The dependent variable will be a dichotomized indicator of any occurrence of unplanned rehospitalization and/or any emergency department/urgent care visit within 30-days post-discharge (i.e. unplanned reutilization). Differences in this outcome between intervention and control groups will be evaluated using logistic regression with the stratification variables (neighborhood poverty and complex versus noncomplex teams) included in the model.
Outcome measures
| Measure |
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=749 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Number of Participants With Any Occurrence of Unplanned Re-hospitalization and/or Any Emergency/Urgent Care Visits Within 30 Days of Hospital Discharge
|
133 Participants
|
105 Participants
|
SECONDARY outcome
Timeframe: 14 days post-dischargePopulation: The analysis population includes the total subjects completing the 14-day phone call survey. Of the total randomized (1,500: 751 intervention, 749 control), 29 were excluded from the intervention group and 26 from the control group.
Post-Discharge Difficulty Coping Scale (Weiss, et. al) measured at 14 day post-discharge phone call. Post-Discharge Coping Difficulty Scale uses an 11 point scaling format (0-10) with total scores ranging from 0 to 100. Higher scores represent greater coping difficulty.
Outcome measures
| Measure |
Home Nurse Visit
n=722 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=723 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Post Discharge Coping Difficulty Scale
|
20.4 units on a scale
Interval 19.1 to 21.8
|
21.2 units on a scale
Interval 19.8 to 22.5
|
SECONDARY outcome
Timeframe: 14 days post-dischargePopulation: The analysis population includes the total subjects completing the 14-day phone call survey with a response for the return to normalcy question. Of the total randomized (1,500: 751 intervention, 749 control), 30 were excluded from the intervention group and 26 from the control group with no data available for this outcome.
Number of days until normalcy: measured at post discharge phone call. Parents asked to recall the number of days it took to "return to a 'normal' routine" including the return to work and school (with option of not yet be back to normal).
Outcome measures
| Measure |
Home Nurse Visit
n=721 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=723 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Days Until Normalcy
|
4.16 days
Interval 3.87 to 4.44
|
4.11 days
Interval 3.82 to 4.4
|
SECONDARY outcome
Timeframe: 14 days post-dischargePopulation: The analysis population includes the total subjects completing the 14-day phone call survey. Of the total randomized (1,500: 751 intervention, 749 control), 29 were excluded from the intervention group and 26 from the control group for not completing the 14-day phone call survey.
This was measured at the 14 day post-discharge phone call survey. Parents were asked to recall "any red flags or warning signs" to indicate the "child's condition was getting worse." The number of red flags recalled could range from 0-10 depending on the template used. The template was a home visit guideline for nurses to use that was specific to the child's illness. For example, if the child had bronchiolitis the nurse would use the template "bronchiolitis/croup/pneumonia" to guide them through the visit. Higher values (i.e., the greater number of red flags remembered) represent a better outcome.
Outcome measures
| Measure |
Home Nurse Visit
n=722 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=723 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Red Flags Remembered
|
1.91 units on a scale
Interval 1.78 to 2.04
|
1.61 units on a scale
Interval 1.5 to 1.73
|
SECONDARY outcome
Timeframe: 30 daysPopulation: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).
Occurrence(s) of an unplanned readmission within 30 days post-discharge.
Outcome measures
| Measure |
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=749 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Number of Participants With Occurrence(s) of an Unplanned Readmission Within 30 Days Post-discharge
|
58 Participants
|
41 Participants
|
SECONDARY outcome
Timeframe: 30 daysPopulation: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).
Occurrence(s) of an ED visit within 30 days post-discharge
Outcome measures
| Measure |
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=749 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Number of Participants With Occurrence(s) of an Emergency Department Visit Within 30 Days Post-discharge
|
75 Participants
|
54 Participants
|
SECONDARY outcome
Timeframe: 14 days post-dischargePopulation: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).
Occurrence(s) of 14-day unplanned healthcare utilization defined by unplanned re-hospitalization and/or any emergency/urgent care visit within 14 days or parent report of an unplanned visit to one of these places. Parent report is collected at the 14 day follow-up phone call.
Outcome measures
| Measure |
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge.
Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
|
Control
n=749 Participants
This arm will receive standard of care.
Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
|
|---|---|---|
|
Number of Participants With Occurrence(s) of 14-day Unplanned Healthcare Utilization
|
132 Participants
|
110 Participants
|
Adverse Events
Home Nurse Visit
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Heidi Sucharew (Biostatistician)
Cincinnati Children's Hospital Medical Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place